FDA Approves Beech Tree Labs' Influenza IND Application.
- (See press release)As recently published in the scientific, peer-reviewed journal, Wound Repair and Regeneration,
Beech Tree Labs' therapeutic agent to reduce scars was shown to increase skin cell mobility and accelerate healing. In separate gene array experiments performed at Beech Tree Labs, detoxified streptolysin O (SLO) was found to directly affect genes involved in regulating the extracellular matrix. Evidence suggests that SLO initiates a cascade of physiologic events contributing to increased migration and proliferation of skin cells and remodeling of the extracellular matrix, thereby quickening wound healing and reducing scarring.Anecdotal studies consistently demonstrate the safety and efficacy of SLO in treating torn tendons, trauma-induced joint scarring, scar-induced contractures, acne, and has promoted healing from surgery. These studies also reveal that patients with old and new burns respond to this therapy.